156 related articles for article (PubMed ID: 18805046)
1. Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma.
Zhang L; Yang X; Pan HY; Zhou XJ; Li J; Chen WT; Zhong LP; Zhang ZY
Oral Oncol; 2009 Jul; 45(7):627-32. PubMed ID: 18805046
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.
Schiegnitz E; Kämmerer PW; Rode K; Schorn T; Brieger J; Al-Nawas B
J Oral Pathol Med; 2016 Jan; 45(1):63-9. PubMed ID: 25880686
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15.
Kong J; Sun W; Zhu W; Liu C; Zhang H; Wang H
J Surg Oncol; 2018 Dec; 118(8):1326-1334. PubMed ID: 30332510
[TBL] [Abstract][Full Text] [Related]
6. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
[TBL] [Abstract][Full Text] [Related]
7. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
8. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of insulin-like growth factor binding protein 3 in oral squamous cell carcinoma.
Zhong LP; Yang X; Zhang L; Wei KJ; Pan HY; Zhou XJ; Li J; Chen WT; Zhang ZY
Oncol Rep; 2008 Dec; 20(6):1441-7. PubMed ID: 19020726
[TBL] [Abstract][Full Text] [Related]
10. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Annexin A2 in oral squamous cell carcinoma.
Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406
[TBL] [Abstract][Full Text] [Related]
13. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
14. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade.
Zhu DW; Yang X; Yang CZ; Ma J; Liu Y; Yan M; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Oral Oncol; 2013 Jun; 49(6):542-50. PubMed ID: 23403091
[TBL] [Abstract][Full Text] [Related]
15. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of CXCR4 in oral squamous cell carcinoma and its influence on proliferation of tumor cells in vitro].
Xu M; Li WY; Chen XM; Wang XH; Huang J; Wang L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):372-5. PubMed ID: 16836911
[TBL] [Abstract][Full Text] [Related]
17. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
19. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
[TBL] [Abstract][Full Text] [Related]
20. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
